SCHEMBL20127388

SCHEMBL20127388

c1ccc(-c2ccc3oc4c5ccccc5c(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)cc4c3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.40
KDM4E B2RXH2 4/20 0.39
MAPT P10636 4/20 0.39
HPGD P15428 3/20 0.39
TSHR P16473 3/20 0.39
HSD17B10 Q99714 3/20 0.39
ALDH1A1 P00352 3/20 0.39
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
PLA2G2A P14555 3/20 0.39
PLA2G4A P47712 3/20 0.39
CYP1A1 P04798 4/20 0.38
CYP1B1 Q16678 3/20 0.38
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127384 0.96 CYP1A1 (0.40) PGRKDM4EMAPTHPGDTSHR
SCHEMBL20127372 0.94 KDM4E (0.40) PGRKDM4EMAPTHPGDTSHR
SCHEMBL20127375 0.92 KDM4E (0.41) PGRKDM4EMAPTHPGDTSHR
SCHEMBL17943891 0.91 ALOX5 (0.41) PGRKDM4EMAPTHPGDTSHR
SCHEMBL25126719 0.90 ALOX5 (0.41) PGRKDM4EMAPTHPGDTSHR
SCHEMBL20127383 0.90 CYP1A1 (0.40) PGRKDM4EMAPTHPGDTSHR
SCHEMBL20127371 0.90 CYP1A1 (0.41) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL20127436 0.90 ALOX5 (0.42) KDM4EMAPTALDH1A1CYP1A1CYP1B1
SCHEMBL10122457 0.89 ALOX5 (0.42) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL16067971 0.88 CYP1A1 (0.46) PGRKDM4EMAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 PGR 1148/4885KDM4E 4144/4885MAPT 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.